Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/astellas-cuts-a-bispecific-in-cancer-and-a-mitochondria-focused-asset-from-mitobridge-deal/
https://endpts.com/astellas-friedreichs-ataxia-gene-therapy-cleared-for-clinical-study-after-earlier-version-stumbled/
https://www.prnewswire.com/news-releases/astellas-xtandi-enzalutamide-granted-european-commission-approval-for-use-in-additional-recurrent-early-prostate-cancer-treatment-setting-302124792.html
https://www.prnewswire.com/news-releases/takeda-astellas-and-sumitomo-mitsui-banking-announce-master-agreement-to-establish-joint-venture-company-for-incubation-of-early-drug-discovery-programs-302123110.html
https://pharmaphorum.com/news/astellas-generic-myrbetriq-defence-knocked-back-again
https://endpts.com/astellas-books-450m-writedown-on-preclinical-gene-therapy-anemia-drug/
https://www.contractpharma.com/contents/view_breaking-news/2024-04-03/cytomx-achieves-5m-astellas-milestone/
https://www.globenewswire.com/news-release/2024/04/03/2856845/37704/en/CytomX-Therapeutics-Announces-Nomination-of-Second-Clinical-Candidate-in-Broad-PROBODY-T-Cell-Engaging-Bispecific-TCB-Collaboration-with-Astellas.html